Truist Securities Maintains Buy on Compugen, Raises Price Target to $5
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
Truist Securities analyst Asthika Goonewardene maintains Compugen (NASDAQ:CGEN) with a Buy and raises the price target from $4 to $5.
Truist Securities analyst Asthika Goonewardene maintains Compugen (NASDAQ:CGEN) with a Buy and raises the price target from $4 to $5.